Date: Thu 01/11/2018 - Sat 31/10/2020
Optometrist Credits: 1 Clinical Diagnostic Credit
Event Type(s): Online
Diabetic macular oedema (DMO) is a complication of diabetic retinopathy and is a leading cause of visual loss worldwide. Development of DMO is linked to duration of disease, poor blood glucose control and in type 2 diabetes, the need for insulin.
With the increasing number of people with diabetes increasing worldwide, the prevalence of DMO is likely to increase, with significant implications for patients in terms of health and social care provision.
This CPD course explains clinical features of DMO and treatment options – from laser to anti- VEGF and intravitreal steroids, discussing NICE guidance on treatment and explaining the findings of clinical trials. It promotes an understanding of the condition and an evidence base for treatment to help practitioners advise and refer patients according to current best practice.